International Biomedicine Management Partners

International Biomedicine Management Partners (IBMP) was a prominent biotechnology venture capital and management firm based in Basel, Switzerland, and San Francisco. Founded in 1997 by Dr. Jürgen Drews, the former President of Global R&D at Roche, and Professor Fritz R. Bühler, the firm specialized in early-stage life science investments and strategic management. IBMP played a significant role in the late 1990s biotech boom, leveraging the deep industry expertise of its partners to fund and advise emerging companies. The firm was known for its 'insider' approach, utilizing the operational experience of former pharmaceutical executives to identify and scale high-potential startups. In late 2000, the firm's leadership team transitioned to Bear Stearns Asset Management to establish Bear Stearns Health Innoventures, effectively ending IBMP's independent operations. The firm remains a notable example of the integration of pharmaceutical leadership into the venture capital landscape.